Target intelligence / Profile preview

Piwi-like RNA-mediated gene silencing 2 (PIWIL2)

Target
PIWIL2
Molecular classification
Argonaute/PIWI protein, Endoribonuclease, Epigenetic modifier, RNA-binding protein
01

Overview

Piwi-like RNA-mediated gene silencing 2 (PIWIL2) is a member of the Argonaute/PIWI protein family, characterized by PAZ and PIWI domains. It is crucial for germline stem cell maintenance and piRNA biogenesis, facilitating repression of transposable elements in the germline and maintaining genomic integrity[2][3]. PIWIL2 functions as an endoribonuclease and epigenetic regulator, modulating chromatin structure and transcription. In cancers, PIWIL2 acts as an oncogene promoting cell proliferation, blocking apoptosis (via STAT3/Bcl-XL signaling), enabling cell cycle progression (G1/S transition), and facilitating metastasis and EMT[1][3]. It is highly expressed in various malignancies and contributes to tumor initiation, progression, and poor prognosis, especially by maintaining cancer stem cell characteristics and reprogramming somatic cells[1][3]. PIWIL2 also stabilizes epigenetic regulators and is involved in DNA damage response and resistance to therapy[3].

Other names
Piwi-like protein 2HILICT80FLJ10351MiliCancer/testis antigen 80Hiwi-likePIWIL1Lmilitesticular tissue protein Li 141
02

Mechanism of action

Therapies targeting PIWIL2 would likely inhibit cell proliferation, induce apoptosis, reduce stemness, and prevent EMT or metastasis in cancer by blocking its effects on the STAT3/Bcl-XL, c-Myc/CyclinD1, and p53/p21/cyclin E/CDK2 pathways[1][3].

03

Biological functions

Germline stem cell maintenancepiRNA-mediated gene silencingTransposon repressionCell cycle regulation (G1/S transition)Inhibition of apoptosisPromotion of cell proliferationEpithelial-mesenchymal transition (EMT)Chromatin remodelingDNA damage responseRegulation of transcriptionTumor stem cell maintenance
04

Disease associations

Cancer (including glioma, breast, colorectal, lung, gastric, bladder, prostate, thyroid)Male infertilityTumor resistance/recurrenceMetastasis
05

Safety considerations

Risks related to germline effects, such as infertility, due to PIWIL2’s role in spermatogenesis[2].Potential off-target epigenetic consequences from disruption of piRNA pathways and genomic stability[2][3].
06

Biomarkers

High PIWIL2 expression as a biomarker for poor prognosis in glioma and other cancers[1][3].Cancer stem cell marker (breast, colorectal, cervical cancers)[3].

Beyond the preview

Go deeper on Piwi-like RNA-mediated gene silencing 2 (PIWIL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Piwi-like RNA-mediated gene silencing 2 (PIWIL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call